Duloxetine (Cymbalta™), a dual inhibitor of serotonin and norepinephrine reuptake

F. P. Bymaster,E. E. Beedle,J. Findlay,P. T. Gallagher,J. H. Krushinski,S. Mitchell,D. W. Robertson,D. C. Thompson,L. Wallace,D. T. Wong

Bioorganic & Medicinal Chemistry Letters（2004）

引用 129|浏览22

暂无评分

摘要

A series of naphthalenyloxy-arylpropylamines have been prepared and are demonstrated to be inhibitors of both serotonin and norepinephrine reuptake. One member of this series, duloxetine (Cymbalta™) has proven to be effective in clinical trials for the treatment of depression.

查看译文

关键词

clinical trial

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要